JP2022540446A5 - - Google Patents
Info
- Publication number
- JP2022540446A5 JP2022540446A5 JP2022500898A JP2022500898A JP2022540446A5 JP 2022540446 A5 JP2022540446 A5 JP 2022540446A5 JP 2022500898 A JP2022500898 A JP 2022500898A JP 2022500898 A JP2022500898 A JP 2022500898A JP 2022540446 A5 JP2022540446 A5 JP 2022540446A5
- Authority
- JP
- Japan
- Prior art keywords
- rna
- composition according
- rhodopsin
- protein
- pathogenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962872604P | 2019-07-10 | 2019-07-10 | |
| US62/872,604 | 2019-07-10 | ||
| US202062968819P | 2020-01-31 | 2020-01-31 | |
| US62/968,819 | 2020-01-31 | ||
| PCT/US2020/041634 WO2021007529A1 (en) | 2019-07-10 | 2020-07-10 | Rna-targeting knockdown and replacement compositions and methods for use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022540446A JP2022540446A (ja) | 2022-09-15 |
| JP2022540446A5 true JP2022540446A5 (enExample) | 2023-07-18 |
Family
ID=71995058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500898A Pending JP2022540446A (ja) | 2019-07-10 | 2020-07-10 | Ｒｎａ標的ノックダウン及び置換の組成物及び使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210009987A1 (enExample) |
| EP (1) | EP3997227A1 (enExample) |
| JP (1) | JP2022540446A (enExample) |
| CN (1) | CN114450031A (enExample) |
| AU (1) | AU2020310201A1 (enExample) |
| CA (1) | CA3145309A1 (enExample) |
| WO (1) | WO2021007529A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011160052A2 (en) | 2010-06-18 | 2011-12-22 | The University Of North Carolina At Chapel Hill | Methods and compositions for sequence specific rna endonucleases |
| EP3901262A1 (en) * | 2020-04-20 | 2021-10-27 | Universität Regensburg | Compositions for use in treating autosomal dominant best1-related retinopathies |
| EP4216964A4 (en) * | 2020-09-24 | 2025-02-12 | Ionis Pharmaceuticals, Inc. | Compounds and methods for reducing apoe expression |
| WO2022119826A1 (en) * | 2020-12-01 | 2022-06-09 | Research Institute At Nationwide Children's Hospital | Products and methods for inhibition of expression of peripheral myelin protein-22 |
| EP4291654A2 (en) | 2021-02-12 | 2023-12-20 | Alnylam Pharmaceuticals, Inc. | Superoxide dismutase 1 (sod1) irna compositions and methods of use thereof for treating or preventing superoxide dismutase 1- (sod1-) associated neurodegenerative diseases |
| WO2022221278A1 (en) * | 2021-04-12 | 2022-10-20 | Locanabio, Inc. | Compositions and methods comprising hybrid promoters |
| WO2022241059A2 (en) * | 2021-05-11 | 2022-11-17 | Mammoth Biosciences, Inc. | Effector proteins and methods of use |
| WO2023015153A2 (en) * | 2021-08-02 | 2023-02-09 | President And Fellows Of Harvard College | ANTISENSE OLIGONUCLEOTIDE TARGETING APOE ε4 AND USES THEREOF |
| US20250288692A1 (en) * | 2021-09-30 | 2025-09-18 | Akouos, Inc. | Compositions and methods for treating kcnq4-associated hearing loss |
| CA3235826A1 (en) * | 2021-10-21 | 2023-04-27 | Wei Hsi Yeh | Genome editing compositions and methods for treatment of usher syndrome type 3 |
| US12173368B2 (en) * | 2022-03-11 | 2024-12-24 | New England Biolabs, Inc. | Compositions and analysis of dephosphorylated oligoribonucleotides |
| US20250195694A1 (en) * | 2022-03-18 | 2025-06-19 | University Of Florida Research Foundation, Incorporated | Methods and compositions for treating tnnt2 related cardiomyopathy with a viral vector |
| EP4519436A4 (en) * | 2022-05-03 | 2026-08-19 | Tacit Therapeutics Inc | LOCALIZATION OF NUCLEIC ACID MOLECULES TRANS-SPLICING TO AND WITHIN THE CELL NUCLEUS |
| WO2024196955A2 (en) * | 2023-03-20 | 2024-09-26 | Duke University | Apoe-targeted microglia-specific gene therapy for neurological diseases |
| EP4766831A1 (en) * | 2023-08-23 | 2026-07-01 | Ohio State Innovation Foundation | PRODUCTION OF TINY RNA INGREDIENTS INSIDE THE CELL |
| WO2025043278A1 (en) * | 2023-08-25 | 2025-03-06 | PYC Therapeutics Limited | Gene-mediated conditions |
| WO2025159427A1 (ko) * | 2024-01-26 | 2025-07-31 | 서울대학교산학협력단 | 신규한 apoe 안티센스 올리고뉴클레오타이드 및 이의 용도 |
| WO2025217591A1 (en) * | 2024-04-12 | 2025-10-16 | Strand Therapeutics Inc. | Human-derived synthetic regulators and uses thereof |
| WO2026010243A1 (ko) * | 2024-07-03 | 2026-01-08 | 주식회사 아바타테라퓨틱스 | Crispr/cas 시스템을 사용하는 best1 유전자 편집 방법 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2623605T3 (en) | 2007-04-09 | 2019-03-25 | Univ Florida | RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF |
| EP2058401A1 (en) * | 2007-10-05 | 2009-05-13 | Genethon | Widespread gene delivery to motor neurons using peripheral injection of AAV vectors |
| CN101895633A (zh) | 2010-07-14 | 2010-11-24 | 中兴通讯股份有限公司 | 一种移动终端及其解锁方法 |
| US9580714B2 (en) | 2010-11-24 | 2017-02-28 | The University Of Western Australia | Peptides for the specific binding of RNA targets |
| US9951349B2 (en) * | 2011-09-27 | 2018-04-24 | Yale University | Compositions and methods for transient expression of recombinant RNA |
| ES2751126T3 (es) | 2011-10-21 | 2020-03-30 | Univ Kyushu Nat Univ Corp | Método de diseño para proteína de unión a ARN usando motivo de PPR, y uso del mismo |
| EP4729528A3 (en) * | 2014-04-25 | 2026-06-24 | Translate Bio, Inc. | Methods for purification of messenger rna |
| US10330674B2 (en) | 2015-01-13 | 2019-06-25 | Massachusetts Institute Of Technology | Pumilio domain-based modular protein architecture for RNA binding |
| CA3091771C (en) * | 2015-03-13 | 2026-04-28 | The Jackson Laboratory | A three-component crispr/cas complex system and uses thereof |
| EP3289080B1 (en) * | 2015-04-30 | 2021-08-25 | The Trustees of Columbia University in the City of New York | Gene therapy for autosomal dominant diseases |
| EP3526324B1 (en) | 2017-03-28 | 2021-08-25 | Locanabio, Inc. | Crispr-associated (cas) protein |
| CN108690861A (zh) * | 2017-04-10 | 2018-10-23 | 肖晓莺 | 用于早期乳腺癌症诊断的微小核糖核酸 |
| US10392616B2 (en) | 2017-06-30 | 2019-08-27 | Arbor Biotechnologies, Inc. | CRISPR RNA targeting enzymes and systems and uses thereof |
| US10476825B2 (en) | 2017-08-22 | 2019-11-12 | Salk Institue for Biological Studies | RNA targeting methods and compositions |
-
2020
- 2020-07-10 JP JP2022500898A patent/JP2022540446A/ja active Pending
- 2020-07-10 AU AU2020310201A patent/AU2020310201A1/en not_active Abandoned
- 2020-07-10 WO PCT/US2020/041634 patent/WO2021007529A1/en not_active Ceased
- 2020-07-10 US US16/926,205 patent/US20210009987A1/en not_active Abandoned
- 2020-07-10 CA CA3145309A patent/CA3145309A1/en active Pending
- 2020-07-10 EP EP20753516.2A patent/EP3997227A1/en not_active Withdrawn
- 2020-07-10 CN CN202080061471.7A patent/CN114450031A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Patil et al. | Rapid evolution and diversification of mammalian α-defensins as revealed by comparative analysis of rodent and primate genes | |
| CN112040988A (zh) | 修饰的aav衣壳多肽用于治疗肌肉疾病 | |
| JP7376018B2 (ja) | 内皮特異的核酸調節エレメントならびにその方法および使用 | |
| US20230053353A1 (en) | Targeting transfer rna for the suppression of nonsense mutations in messenger rna | |
| Hagiwara et al. | Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif | |
| JP2024520528A5 (enExample) | ||
| JP2017506885A (ja) | アデノ随伴ウイルスベクターの高力価産生 | |
| JP2018078898A (ja) | 肝特異的核酸調節要素ならびにその方法および用途 | |
| JP2021526858A5 (enExample) | ||
| CN111218446B (zh) | 一种肝脏特异性启动子及其应用 | |
| JP2021532776A5 (enExample) | ||
| US20250059564A1 (en) | Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer | |
| JP2024518817A5 (enExample) | ||
| CN110393791A (zh) | hnRNPA2B1的抗感染作用及其应用 | |
| KR20250053925A (ko) | CRISPR-Cas13 시스템 및 이의 용도 | |
| JP2024523394A5 (enExample) | ||
| JP2022542294A5 (enExample) | ||
| JP2023544702A5 (enExample) | ||
| JP2024529108A5 (enExample) | ||
| JP2006524491A5 (enExample) | ||
| JP7626423B6 (ja) | 線維症治療薬 | |
| JP2021529519A5 (enExample) | ||
| WO2025229995A1 (ja) | 核酸導入用ベクター、核酸導入方法、ポリヌクレオチド、及びベクター | |
| CN118703545A (zh) | 一种促进iNKT细胞精准再识别iNKT免疫逃逸型胰腺癌肿瘤细胞亚群的基因线路 | |
| US20230220361A1 (en) | Crispr-cas9 mediated disruption of alcam gene inhibits adhesion and trans-endothelial migration of myeloid cells |